Sandesh Seth - 28 Dec 2023 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATNM	Stock Option (Right to Buy)	Award	$0	+984,367		$0.000000	984,367	28 Dec 2023	Common Stock	984,367	$5.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant.
F2	Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested.